Literature DB >> 23392092

Gonadotropin resistance.

Ana Claudia Latronico1, Ivo Jorge Prado Arnhold.   

Abstract

Pituitary gonadotropins are essential for normal reproductive function. LH and FSH exert their effects by acting on G protein-coupled receptors. Pituitary LH and placental hCG share the same receptor (LHCGR). Homozygous or compound heterozygous inactivating mutations of LHCGR are associated with a phenotypic spectrum from female or ambiguous external genitalia due to Leydig cell hypoplasia to micropenis, hypergonadotropic hypogonadism and delayed puberty in genetic males. Testes size is slightly reduced, and testosterone levels are low in affected males. Interestingly, the clinical phenotypes are closely correlated with the severity of the mutation. In females, the phenotype is also variable and can range from primary amenorrhea to oligoamenorrhea, associated with constant infertility. Estradiol and progesterone levels remain in the early to mid-follicular phase, whereas the ovaries are normal or enlarged with cysts. In both sexes, LH levels are increased, whereas FSH is usually normal. Inactivating mutations of FSH receptor are associated with partial to complete premature ovarian failure in women and variable impairment of spermatogenesis and small testes in men. Mutations of the human gonadotropin receptors provide natural models for elucidating the differential effects of LH and FSH on the gonads.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392092     DOI: 10.1159/000342496

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  6 in total

1.  Rare diseases in clinical endocrinology: a taxonomic classification system.

Authors:  G Marcucci; L Cianferotti; P Beck-Peccoz; M Capezzone; F Cetani; A Colao; M V Davì; E degli Uberti; S Del Prato; R Elisei; A Faggiano; D Ferone; C Foresta; L Fugazzola; E Ghigo; G Giacchetti; F Giorgino; A Lenzi; P Malandrino; M Mannelli; C Marcocci; L Masi; F Pacini; G Opocher; A Radicioni; M Tonacchera; R Vigneri; M C Zatelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  2014-11-07       Impact factor: 4.256

2.  Comparative Study of the Restoring Effect of Metformin, Gonadotropin, and Allosteric Agonist of Luteinizing Hormone Receptor on Spermatogenesis in Male Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus.

Authors:  K V Derkach; A A Bakhtyukov; I Yu Morina; I V Romanova; L V Bayunova; A O Shpakov
Journal:  Bull Exp Biol Med       Date:  2022-02-17       Impact factor: 0.804

3.  GATA4 Variants in Individuals With a 46,XY Disorder of Sex Development (DSD) May or May Not Be Associated With Cardiac Defects Depending on Second Hits in Other DSD Genes.

Authors:  Idoia Martinez de LaPiscina; Carmen de Mingo; Stefan Riedl; Amaia Rodriguez; Amit V Pandey; Mónica Fernández-Cancio; Nuria Camats; Andrew Sinclair; Luis Castaño; Laura Audi; Christa E Flück
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-04       Impact factor: 5.555

4.  The impact of FSH receptor polymorphism on time-to-pregnancy: a cross-sectional single-centre study.

Authors:  Birute Zilaitiene; Marius Dirzauskas; Rasa Verkauskiene; Rytas Ostrauskas; Joerg Gromoll; Eberhard Nieschlag
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-28       Impact factor: 3.007

5.  The Effects of Separate and Combined Treatment of Male Rats with Type 2 Diabetes with Metformin and Orthosteric and Allosteric Agonists of Luteinizing Hormone Receptor on Steroidogenesis and Spermatogenesis.

Authors:  Andrey A Bakhtyukov; Kira V Derkach; Viktor N Sorokoumov; Anna M Stepochkina; Irina V Romanova; Irina Yu Morina; Irina O Zakharova; Liubov V Bayunova; Alexander O Shpakov
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

6.  Comparative Study of the Steroidogenic Effects of Human Chorionic Gonadotropin and Thieno[2,3-D]pyrimidine-Based Allosteric Agonist of Luteinizing Hormone Receptor in Young Adult, Aging and Diabetic Male Rats.

Authors:  Andrey A Bakhtyukov; Kira V Derkach; Maxim A Gureev; Dmitry V Dar'in; Viktor N Sorokoumov; Irina V Romanova; Irina Yu Morina; Anna M Stepochkina; Alexander O Shpakov
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.